AM Langkilde

727 total citations · 1 hit paper
11 papers, 613 citations indexed

About

AM Langkilde is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, AM Langkilde has authored 11 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in AM Langkilde's work include Diabetes Treatment and Management (5 papers), Nutrition and Health in Aging (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). AM Langkilde is often cited by papers focused on Diabetes Treatment and Management (5 papers), Nutrition and Health in Aging (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). AM Langkilde collaborates with scholars based in Sweden, United States and United Kingdom. AM Langkilde's co-authors include Shamik Parikh, C. David Sjöström, Östen Ljunggren, Lars Johansson, Jan Bolinder, Jennifer Sugg, John Wilding, Jiadan Yang, N. Ueda and Kohei Kaku and has published in prestigious journals such as European Journal of Clinical Nutrition, Diabetes Obesity and Metabolism and Kidney International Reports.

In The Last Decade

AM Langkilde

11 papers receiving 595 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

2013 389 citations Jan Bolinder, Östen Ljunggren et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
AM Langkilde Sweden	6	488	328	222	105	78	11	613
M. Traversa Italy	7	399 0.8×	103 0.3×	98 0.4×	45 0.4×	141 1.8×	12	630
Kazuhiko Takano Japan	8	154 0.3×	198 0.6×	91 0.4×	24 0.2×	61 0.8×	14	401
Anne‐Marie Mølck Denmark	10	160 0.3×	114 0.3×	136 0.6×	30 0.3×	33 0.4×	22	352
Mitsutoshi Kato Japan	11	168 0.3×	130 0.4×	51 0.2×	23 0.2×	47 0.6×	30	401
H J Ziegelasch Germany	2	603 1.2×	155 0.5×	108 0.5×	59 0.6×	81 1.0×	2	710
M Cerri Italy	10	136 0.3×	81 0.2×	89 0.4×	39 0.4×	171 2.2×	13	430
Toshiki Hozumi Japan	10	157 0.3×	117 0.4×	88 0.4×	19 0.2×	56 0.7×	19	337
Elisabeth Hjøllund Denmark	12	197 0.4×	161 0.5×	97 0.4×	28 0.3×	224 2.9×	24	508
V J Heiling United States	11	290 0.6×	117 0.4×	115 0.5×	33 0.3×	375 4.8×	13	677
Shinpei Morimoto Japan	13	207 0.4×	96 0.3×	86 0.4×	17 0.2×	53 0.7×	61	456

Countries citing papers authored by AM Langkilde

Since Specialization

Citations

This map shows the geographic impact of AM Langkilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AM Langkilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AM Langkilde more than expected).

Fields of papers citing papers by AM Langkilde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AM Langkilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AM Langkilde. The network helps show where AM Langkilde may publish in the future.

Co-authorship network of co-authors of AM Langkilde

This figure shows the co-authorship network connecting the top 25 collaborators of AM Langkilde. A scholar is included among the top collaborators of AM Langkilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AM Langkilde. AM Langkilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Bjornstad, Petter, et al.. (2021). The potential roles of osmotic and non-osmotic sodium handling in mediating effects of SGLT2 inhibitors on heart failure. UCL Discovery (University College London). 1 indexed citations

2.

Heerspink, Hiddo J.L., Robert D. Toto, Niels Jongs, et al.. (2021). POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL. Kidney International Reports. 6(4). S362–S362. 1 indexed citations

3.

Raz, Itamar, Ofri Mosenzon, Avivit Cahn, et al.. (2018). Ausgangscharakteristika der DECLARE-TIMI-58-Studienpopulation. Diabetologie und Stoffwechsel. 4 indexed citations

4.

Kaku, Kohei, Arihiro Kiyosue, Shin‐ichiro Inoue, et al.. (2014). Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise. Diabetes Obesity and Metabolism. 16(11). 1102–1110. 99 indexed citations

5.

Grandy, Susan, Mahdi Hashemi, AM Langkilde, Shamik Parikh, & C. David Sjöström. (2014). Changes in weight loss‐related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin. Diabetes Obesity and Metabolism. 16(7). 645–650. 39 indexed citations

6.

Bolinder, Jan, Östen Ljunggren, Lars Johansson, et al.. (2013). Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obesity and Metabolism. 16(2). 159–169. 389 indexed citations breakdown →

7.

Strojek, Krzysztof, Kun‐Ho Yoon, Veronika Hrubá, et al.. (2013). Effekt von Dapagliflozin bei Typ-2-Diabetikern mit unzureichender Blutzuckereinstellung unter Glimepirid. DMW - Deutsche Medizinische Wochenschrift. 138(S 01). S16–S27. 2 indexed citations

8.

Langkilde, AM, H. Ekwall, I. Björck, NG Asp, & Henrik Andersson. (1998). Retrograded high-amylose corn starch reduces cholic acid excretion from the small bowel in ileostomy subjects. European Journal of Clinical Nutrition. 52(11). 790–795. 17 indexed citations

9.

Langkilde, AM & Henrik Andersson. (1992). Nutrients and sterols excreted in ileostomy effluents after a diet with autoclaved amylomaize or ordinary corn starch.. PubMed. 46 Suppl 2. S127–S127. 2 indexed citations

10.

Langkilde, AM, Henrik Andersson, Thomas F. Schweizer, & Inga Torsdottir. (1990). Nutrients excreted in ileostomy effluents after consumption of mixed diets with beans or potatoes. I. Minerals, protein, fat and energy.. PubMed. 44(8). 559–66. 16 indexed citations

11.

Schweizer, Thomas F., et al.. (1990). Nutrients excreted in ileostomy effluents after consumption of mixed diets with beans or potatoes. II. Starch, dietary fibre and sugars.. PubMed. 44(8). 567–75. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact